Tacrolimus as second-line therapy in acute severe autoimmune hepatitis: Scandinavian Journal of Gastroenterology: Vol 56, No 3

177

Views

CrossRef citations to date

Altmetric

"Tacrolimus as second-line therapy in acute severe autoimmune hepatitis." Scandinavian Journal of Gastroenterology, 56(3), p. 298

Disclosure statement

No potential conflict of interest was reported by the author(s).

Table 1. Baseline Characteristics and outcomes of AIH patients with features of severe liver failure.

Download CSV Display Table

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Tacrolimus as second-line therapy in acute severe autoimmune hepatitis

Table 1. Baseline Characteristics and outcomes of AIH patients with features of severe liver failure.

Information for

Open access

Opportunities

Help and information

Tacrolimus as second-line therapy in acute severe autoimmune hepatitis

Disclosure statement

Table 1. Baseline Characteristics and outcomes of AIH patients with features of severe liver failure.

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature